BEACON has partnered with LifeArc to help patient group leaders and academics team up to begin repurposing research on their specific rare condition.

Join us for a 3-part educational series that progresses through the drug repurposing journey using LifeArc’s newly developed Drug Repurposing toolkit that’s been designed with patient groups and academics in mind!

It takes a village to bring a licensed treatment to market, especially when developing it from scratch. Drug repurposing provides hope.

Register now to learn how to navigate the drug repurposing landscape and bring a repurposed therapy to market!

Dates of 3-part educational series: 8th February, 22nd February, 8th March

Please note: This educational series is for leaders of rare disease patient groups and those within them that have a medical/scientific interest in drug development and repurposing. Academics who are thinking of getting involved in rare repurposing and research are highly encouraged to attend this series, as it’s been designed specifically to benefit you!